LHLi Hong

Li Hong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Li Hong has a total of 206 co-authors. Here are the top co-authors by number of shared publications:

  • Liya Pan

    Shanghai Children's Medical Center

    12 shared publications
  • Zhiyan Zhan

    Department of Clinical Nutrition, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

    11 shared publications
  • Jing Li

    Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

    5 shared publications
  • Rui Zhang

    Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China

    5 shared publications
  • Yi Feng

    Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    5 shared publications
  • Chengchen Zhang

    Shanghai Children's Medical Center

    4 shared publications

Latest Publications

  • Open Access

    Metabolic and nutritional toxicities associated with antibody-drug conjugates: a combined analysis of a pediatric relapsed/refractory B-cell acute lymphoblastic leukemia cohort and the FAERS database

    by Chenwai Xiao, Kefei Wu, Kunlin Pei, Jing Wu, Yingyi He, Wenting Hu, Claudio Romano, Hui Zhang, Zhuo Wang, Li Hong

    Background: Antibody-drug conjugates (ADCs) are increasingly prescribed in anti-tumor treatment; however, metabolism and nutrition disorders (MNDs) during ADC therapy remain insufficiently characterized. We evaluated short-term nutritional changes after inotuzumab ozogamicin (INO) in a pediatric relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) cohort and separately assessed ADC-associated MND reporting signals in the FDA Adverse Event Reporting System (FAERS). Methods: We identified 146 children with R/R B-ALL who initiated INO or non-INO salvage therapy between January 2014 and June 2025. Of these, 143 had evaluable body-weight measurements at baseline and 1 month and comprised the primary endpoint population, including 73 patients treated with INO and 70 treated with non-INO salvage therapy. The primary endpoint was body weight change from baseline to 1 month after treatment initiation, with clinically significant weight change defined as an absolute change of ≥5% from baseline. Propensity scores were estimated using treatment assignment (INO vs. non-INO) as the dependent variable, followed by 1:1 nearest-neighbor matching without replacement (caliper, 0.10); 34 matched pairs were included, and clinically significant weight change was analyzed using matched-pair methods. In parallel, FAERS reports from January 2004 through September 2024 were analyzed using reporting odds ratios (RORs) to identify disproportionate MND reporting signals, and univariate logistic regression was used to explore report-level correlates. Set-based analyses were used to assess co-reporting patterns of MNDs with recorded death or disease progression. Results: Pediatric patients with R/R B-ALL receiving INO showed a higher frequency of clinically significant weight change than matched patients receiving non-INO salvage therapy (24/34 vs. 7/34; exact McNemar p < 0.001). In FAERS, MNDs accounted for 8.1% of ADC-associated AE reports, with an overall disproportionate reporting signal (ROR, 1.72; 95% CI, 1.67–1.78). Among MND reports, 11.5% also reported death or disease progression. Microtubule inhibitor ADCs showed slightly higher MND reporting odds than non-microtubule inhibitor ADCs (OR, 1.17; 95% CI, 1.04–1.32; p = 0.009). ADCs also showed disproportionate reporting of several nutritional complications compared with conventional chemotherapy. Conclusion: In the pediatric cohort, INO treatment was associated with greater short-term weight changes than non-INO salvage therapy, while FAERS identified disproportionate reporting signals for several MNDs across ADCs. These findings highlight the potential importance of nutritional evaluation and individualized nutritional support during ADC therapy, although their clinical benefits require further prospective evaluation.

  • Open Access

    Nonlinear Association Between Lithocholic Acid-Related Metabolism and Dysglycemia in Pediatric Obesity

    by Lingwen Ying, Fan Yang, Jiayue Hu, Jiaxiao She, Biyun Feng, Qianwen Zhang, Yiguo Huang, Libo Wang, Juan Li, Yu Ding, et al.

    Background: Bile acids regulate glucose metabolism through enterohepatic signaling and gut microbiota-mediated transformations. However, the role of specific bile acid subtypes, particularly lithocholic acid (LCA) and its derivatives, in pediatric obesity remains incompletely understood. Methods: In this cross-sectional study, 149 children with obesity underwent comprehensive metabolic assessment, including a 75-g oral glucose tolerance test (OGTT) and fasting serum bile acid profiling using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Bile acid-derived indices were used for unsupervised clustering to identify metabolic phenotypes. Associations between LCA-related indices and dysglycemia (defined as HbA1c ≥ 5.7% and/or 2-h plasma glucose ≥ 7.8 mmol/L) were evaluated using multivariable regression models. The LCA derivative sum was analyzed separately using tertile categories and continuous linear and quadratic models. Cluster-stratified patterns were further assessed. Results: Three bile acid-derived clusters with distinct metabolic profiles were identified. Despite similar anthropometric characteristics, clusters differed significantly in glycemic status and insulin dynamics. LCA-related bile acid indices showed a non-monotonic redistribution across clusters. Compared with the lowest tertile, adjusted odds ratios for dysglycemia were 1.44 (95% CI: 0.62–3.37) for the intermediate tertile and 0.33 (0.13–0.83) for the highest tertile. The continuous linear model showed an inverse association per SD increase (OR 0.646 [0.441–0.946]). A separate continuous quadratic model suggested an inverted U-shaped exposure–response pattern, describing variation across the continuous exposure range rather than comparisons between tertile categories. Interaction analyses did not demonstrate a statistically significant modification of the association for the primary outcome, although analyses of continuous glycemic traits suggested potential heterogeneity across clusters. Conclusions: Bile acid-based clustering identifies distinct metabolic phenotypes in pediatric obesity. LCA-related bile acid metabolism shows nonlinear associations with dysglycemia and may exhibit heterogeneity across metabolic phenotypes. These findings highlight the importance of considering bile acid subtype specificity and metabolic context in understanding bile acid–glucose interactions.

  • Open Access

    ApoE and Fibroblast–Macrophage Interaction in the Aganglionic Segment of Hirschsprung’s Disease-Associated Enterocolitis

    by Qihui Shao, Zhulin Wang, Yifan Fang, Jing Li, Wenxi Zhu, Bing Zhang, Fei Chen, Zhilong Yan, Zhiyan Zhan, Li Hong

    Background: The pathogenesis of Hirschsprung’s disease-associated enterocolitis (HAEC) remains unclear. Currently, no definitive studies have elucidated the communication between intestinal macrophages and fibroblasts during the development of HAEC, nor their specific functional roles in this process. Methods: The first step is utilizing single-cell transcriptomics and spatial transcriptomic sequencing techniques to validate the phenotypes and corresponding spatial location characteristics of intestinal fibroblasts in the patient with HAEC. The second is verifying the mechanism whereby specific subtypes of fibroblasts and macrophages communicate via apolipoprotein E (ApoE) and modulate corresponding inflammatory pathways using co-culture, Western blot and other molecular biology techniques. Results: As HAEC progressed, JUN expression was significantly upregulated in CTHRC1+PRRX1+ fibroblasts enriched in the submucosal layer in the aganglionic segment. In vitro experiments showed JUN-overexpressing 3T3-L1 cells exhibited increased ApoE secretion. ApoE may interact with macrophages and potentially suppress their inflammation through the p38/MAPK and NF-κB pathways. Conclusions:CTHRC1+PRRX1+ fibroblasts and ApoE may represent a potential mechanistic target for future investigation into inhibiting the progression of the aganglionic segment in HAEC and treating colitis.

  • Open Access

    Food-based formula modulates gut microbial homeostasis and inflammatory responses following LPS challenge in mice

    by Xiaolan Ying, Jing Li, Yue Tang, Guoliang Lu, Li Hong, Zhiyan Zhan

    Background: Oral nutritional supplements (ONSs) are widely used to support patients with malnutrition or chronic diseases. However, their potential effects on inflammatory recovery and gut microbial composition remain insufficiently understood. This study evaluated a novel whole-food-based formula (FBF) composed of natural food-derived ingredients and investigated its effects on inflammation recovery and gut microbiota in a murine model of lipopolysaccharide (LPS)-induced low-grade inflammation. Methods: 21 male C57BL/6J mice were randomly assigned to a healthy control (HC) group, a milk-based formula (MBF) group, or a food-based formula (FBF) group. Mild systemic inflammation was induced by intraperitoneal injection of LPS (3 mg/kg). After LPS administration, mice received dietary intervention for 10 days. Serum inflammatory cytokines, colonic histopathology, and gut microbiota profiles were evaluated by ELISA, hematoxylin–eosin staining, and 16S rRNA gene sequencing, respectively. Results: Serum IL-6 concentrations were elevated in the MBF group compared with healthy controls ( p < 0.05), whereas no significant difference was observed between the FBF group and healthy controls. Histological evaluation showed a tendency toward reduced mucosal disruption and inflammatory cell infiltration in FBF-treated mice, although the differences in histological scores were not statistically significant. FBF was also associated with increased microbial richness and diversity, as indicated by higher ACE, Chao1, Shannon, and Simpson indices. Principal coordinate analysis and non-metric multidimensional scaling revealed a microbial community structure closer to that of healthy controls in the FBF group. Taxonomic analysis revealed that FBF reduced the relative abundance of Erysipelotrichaceae and maintained Lachnospiraceae_NK4A136_group abundance. Conclusion: A whole-food-based nutritional formula was associated with lower serum IL-6 levels and distinct gut microbial compositional profiles compared with a milk-based formula following LPS-induced inflammation. These findings suggest FBF may influence inflammatory recovery and gut microbial composition; however, further functional and mechanistic studies are required to clarify its biological effects.

  • Open Access

    Association between dietary diversity in complementary feeding and growth and nutritional status among children aged 0–36 months in China: a cross-sectional study

    by Li Hong, Yunman Liu, Qihui Shao, Yizhi Wang, Chengchen Zhang, Liya Pan, Zhuoqi Zhao, Yuyun Chen

    Objective: To assess complementary feeding practices among Chinese parents and to investigate the associations between dietary diversity in complementary feeding and growth outcomes in children aged 0–36 months. Methods: This national cross-sectional study included 26,266 children aged 0–36 months from 33 provinces in China. Participants were recruited through a convenience sampling strategy. Self-reported questionnaires were designed and posted on the website of the China Maternal and Child Health Association, which collected the information of assessing complementary feeding practices and knowledge. Anthropometric indicators (length/height, weight, and weight-for-length/height) were evaluated using World Health Organization growth standards. Dietary diversity was defined based on the daily consumption of multiple complementary food groups. Correlation analyses and multivariable regression models were conducted to evaluate associations between dietary diversity, specific food groups, and growth outcomes. Results: A high proportion of children were classified above the 90th percentile for weight across regions (range: 39.39–51.83%). Dietary diversity was positively associated with linear growth in all age groups, with the strongest association observed among children aged 19–36 months ( r = 0.2769, p < 0.05). Conversely, dietary diversity was negatively associated with weight-for-length/height in children older than 6 months and with weight gain among those aged 13–18 months ( r = −0.0602, p < 0.05). Iron and protein-rich foods, such as liver and animal blood, were underutilized, particularly in younger children. Additionally, 13.13% of parents reported limited experience in complementary feeding, and more than half prioritized DHA supplementation over whole-food diversity. Conclusion: Chinese children aged 0–36 months may be at risk of high body weight status. Greater dietary diversity in complementary feeding may support optimal linear growth while helping to mitigate excessive weight gain. Given the observed gap between parental knowledge and feeding practices, targeted nutrition education and guidance on responsive feeding are urgently needed from a public health perspective.

  • Age-associated outcomes of ERCP in pediatric chronic pancreatitis

    by Yu Zhu, Tianao Zhang, Sheng Ding, Biao Gong, Li Hong, Zhaohui Deng

  • Open Access

    Compact Gut Microbial Dysbiosis Signature Associated with Necrotizing Enterocolitis and Altered Early Microbiota Development

    by Ying Xiang, Zhuoqi Zhao, Zhong Feng, Jialu Zhuang, Yu Chen, Yansong Chen, Shumin Feng, Liya Pan, Zhilong Yan, Li Hong

    Background: Necrotizing enterocolitis (NEC) is a life-threatening intestinal disorder in preterm infants and is strongly associated with gut microbial dysbiosis. However, whether recurrent genus-level dysbiosis patterns can be observed across heterogeneous NEC cohorts and summarized as a compact, interpretable microbial signature remains unclear. Methods: We analyzed two public neonatal gut microbiome cohorts and an independent real-world cohort within a three-stage framework of discovery, contextual analysis, and external validation. Community composition, alpha diversity, beta diversity, and differential genera were evaluated using harmonized genus-level features within each cohort. Machine learning feature prioritization was used to derive a reduced NEC-associated microbial signature. A four-group cohort was then used to examine this signature in relation to disease status, antibiotic exposure, and early postnatal development. The reduced signature was finally examined in our collected samples. Results: NEC-related microbial alterations showed marked heterogeneity at the whole-community level across cohorts, whereas several genus-level directional patterns recurred across datasets. Across datasets, NEC was repeatedly associated with enrichment of several opportunistic genera, including Enterobacter, Klebsiella, Serratia, and Escherichia–Shigella, and depletion of commensal or probiotic-associated taxa such as Bifidobacterium, Lactobacillus, and Pediococcus. Feature prioritization yielded a compact microbial signature that improved discrimination over the unfiltered abundance profile in the discovery cohort (AUC 0.674 vs. 0.59). In the four-group cohort, the NEC_ABT group remained distinct from healthy controls, supporting partial modification rather than normalization of the NEC-associated pattern. In our collected samples, the signature retained directional consistency but showed only modest external discrimination (AUC 0.618). Conclusions: These findings identify recurrent genus-level dysbiosis features associated with NEC across clinically heterogeneous settings. The compact microbial signature may serve as an exploratory biomarker for longitudinal and mechanistic validation, but not as a standalone diagnostic tool.

  • Open Access

    Longitudinal FeNO monitoring in pediatric asthma: association of FeNO and its trajectory patterns with asthma control status

    by Xiaolan Ying, Yiting Chen, Lu Liu, Yufen Wu, Jiajun Yuan, Hong Li, Yong Yin

    Background: Fractional exhaled nitric oxide (FeNO) is a non-invasive biomarker of type 2 inflammation with potential for personalized asthma management. However, the longitudinal patterns of FeNO and their association with childhood asthma control remain insufficiently characterized. Methods: This cohort study enrolled children with newly diagnosed asthma from Shanghai Children’s Medical Center. Participants underwent baseline assessments and serial FeNO measurements at diagnosis and at 3-month intervals over 12 months. Asthma control was assessed at 12 months using Global Initiative for Asthma (GINA) criteria. Longitudinal trajectories of FeNO were identified using group-based trajectory modeling (GBTM). Associations of time-specific FeNO levels and FeNO trajectory group with uncontrolled asthma at 12 months were analyzed using logistic regression. Results: Among 142 children (mean age 6.92 ± 2.08 years; 71.1% male), 125 (88.0%) achieved controlled asthma and 17 (12.0%) had uncontrolled asthma at 12 months. Elevated FeNO at 3 and 12 months was significantly associated with increased odds of uncontrolled asthma after adjusting for covariates. Longitudinal FeNO levels showed two distinct trajectories: low-stable (80.3% of participants) and high-rising (19.7%). Compared with the low-stable group, the high-rising group had significantly older age, later wheezing onset, higher serum total immunoglobulin E (IgE) and eosinophil percentages (all p < 0.05). Children in the high-rising trajectory group had higher odds of uncontrolled asthma (OR = 5.86; 95% CI: 1.28–29.57; p = 0.025). Conclusions: Elevated FeNO levels during follow-up and a high-rising FeNO trajectory are associated with uncontrolled asthma at 12 months in children with newly diagnosed asthma. Longitudinal FeNO monitoring may help identify children at increased risk of poor asthma control and support more individualized asthma management.

  • Macrophages with ITIH4 overexpression attenuate inflammatory responses and regulate intestinal epithelial cells

    by Jing Li, Zhuoqi Zhao, Jun Fei, Rui Zhang, Liya Pan, Ying Xiang, Li Hong, Zhiyan Zhan

    Inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) is an acute phage protein and secretory protein that is highly related to inflammation. However, the expression profile and function of ITIH4 in macrophage-mediated inflammation are still unclear. Quantitative proteomics based on mass spectrometry was performed to explore differential protein expression in bone marrow-derived macrophages (BMDMs) subjected to the indicated treatments. Western blot and qRT-PCR assays were performed to confirm the expression of ITIH4 in macrophages. ITIH4 was overexpressed and knocked down in Raw264.7 cells, and ITIH4 was knocked down in THP-1 cells, after which the function and molecular mechanism of ITIH4 in macrophages were investigated. Immunohistochemical staining and online bioinformatics tools were used to explore the expression of ITIH4 in the inflamed colon. In addition, CCK8, scratch wound healing, RNA-seq, qRT-PCR and Western blot assays were performed to explore the function and mechanism of macrophages with ITIH4 overexpression in colonic epithelial cells. Our findings demonstrated that the expression of full-length ITIH4 increased in pro-inflammatory macrophages resulting from a decrease in cleavage, whereas treatment with 4-octyl itaconate (OI) promoted the synthesis and secretion of full-length ITIH4. We overexpressed or knocked down ITIH4 in macrophages, subsequently revealed that ITIH4 modulated anti-inflammatory responses via the NF-κB signaling pathway in macrophages. Moreover, macrophages with ITIH4 overexpression activated cAMP signaling pathway to enhance the viability and tight junction integrity of colonic epithelial cells. This study suggests that ITIH4 plays crucial roles in the inflammatory response of macrophages and may be an important molecule that regulates macrophage-epithelium interactions. Our findings shed new light into the molecular mechanism underlying macrophage drives intestinal inflammation and highlight ITIH4 as a therapeutic target for mitigating macrophages-induced intestinal damage.

  • Open Access

    Resurgence and clinical evolution of influenza A in Chinese children: shifting epidemiology and serological dynamics across pre-, intra-, and post-pandemic eras (2019–2023)

    by Guiling Xu, Yu Chen, Yu Zhu, Qing Fang, Xiaotong Xue, Kejun Hu, Sha Zhou, Li Hong, Ying Xiang

    This study aimed to analyze the epidemiological characteristics and hematologic and inflammatory markers of influenza A in children aged 0–18 years b